✨ Free AI Report
AFT Pharmaceuticals Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research AFT Pharmaceuticals Limited
Company Research

AFT Pharmaceuticals Limited: Business Overview, Financials & Competitive Analysis

AFT Pharmaceuticals develops, markets, and distributes pharmaceutical products across allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, and hospital applications in New Zealand,...

Analyst-debate audio for AFT Pharmaceuticals Limited

AskCyborg analysts argue the bull and bear cases for AFT Pharmaceuticals Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Focused pharma innovator with strong home market position, proven pipeline execution, and clear path to NZ$300M revenue by...

Read the full analyst-debate transcript →
Industry Pharmaceutical Manufacturing and Distribution
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest AFT Pharmaceuticals Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

AFT Pharmaceuticals Limited Overview

Pro stress-test →

AFT Pharmaceuticals develops, markets, and distributes pharmaceutical products across allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, and hospital applications in New Zealand, Australia, Asia, and internationally. The company has set a goal of achieving NZ$300 million in revenue by the end of 2027.

Strategic Profile

Pro stress-test →

AFT has an R&D collaboration with Belgium's Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy. The company's product line extends to over 130 prescription and non-prescription products in Australasia with offices in Singapore, Kuala Lumpur, Sydney and Auckland. AFT exports or licenses products to over 109 countries.

Competitive Landscape

Pro stress-test →

AFT competes in the generic and branded pharmaceuticals sector against both multinational companies and regional players. Key competitive advantages include proprietary formulations (particularly Maxigesic combination products), established distribution networks across Australasia, and a robust pipeline of innovative injectable therapies developed through strategic partnerships.

Industry Context

AFT Pharmaceuticals Limited operates in Pharmaceutical Manufacturing and Distribution.

Key facts

Founded: 1997 · Headquarters: Auckland, New Zealand · Revenue: NZ$300M target (FY2027)

What the analysts stress-tested

The top findings that survived the multi-agent debate for AFT Pharmaceuticals Limited.

  • US FDA approved Maxigesic IV, representing the company's second FDA approval within one year.
  • Hikma Pharmaceuticals' first sale of Maxigesic IV triggered a US$6 million license fee payment to AFT.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • September 2025Strong H1 FY2026 performance with 3% revenue growth tracking toward NZ$300M FY27 target
  • 2025FDA approval of Maxigesic IV and extended US licensing agreement with Hikma Pharmaceuticals
  • +1 moreTrack every material event for AFT Pharmaceuticals Limited as it happens. Explore monitoring →
Get alerted when AFT Pharmaceuticals Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Paracetamol/Ibuprofen combinationsOTC pain relief products→Injectable iron therapiesIron deficiency treatment solutions→Eye care productsOphthalmic care formulations→

Compare AFT Pharmaceuticals Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

AFT Pharmaceuticals Limited operates in Pharmaceutical Manufacturing and Distribution. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Manufacturing and Distribution research →
NEW · MCP server

Ask your AI assistant about AFT Pharmaceuticals Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare AFT Pharmaceuticals Limited and its top competitor on Cyborg Score”
“What did AFT Pharmaceuticals Limited do this quarter?”
“Is AFT Pharmaceuticals Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does AFT Pharmaceuticals Limited do?+
AFT Pharmaceuticals develops, markets, and distributes pharmaceutical products across allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, and hospital applications in New Zealand,...
What is AFT Pharmaceuticals Limited's Cyborg Score?+
AFT Pharmaceuticals Limited has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are AFT Pharmaceuticals Limited's main competitors?+
Named competitors include Paracetamol/Ibuprofen combinations, Injectable iron therapies, Eye care products. The full competitive landscape is in the AskCyborg report.
How can I get the full AFT Pharmaceuticals Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the AFT Pharmaceuticals Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track AFT Pharmaceuticals Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.